Patent directory · USPTO A61K / A61P
Patents matching “The Board of Regents of the University of Oklahoma”
179 pharma patents match "The Board of Regents of the University of Oklahoma" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 179 pharmaceutical patents matching "The Board of Regents of the University of Oklahoma" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11446365
Antimalarial enzyme conjugates, kits containing same, and methods of producing and using same
granted -
US 11447452
Agonists of peroxisome proliferator-activated receptor alpha and methods of use
granted -
US 11414458
Identification of MHC class I phospho-peptide antigens from breast cancer utilizing SHLA technology and complementary enrichment strategies
granted -
US 11369575
PPARα agonist compositions and methods of use
granted -
US 11337968
Phenylquinoline compositions for treatment of ocular disorders and conditions
granted -
US 11311526
Radiation mitigator and method of use thereof
granted -
US 11305002
Compositions and treatments for Haemophilus influenzae
granted -
US 11230569
Antiplasmodial compounds
granted -
US 11203582
Benzamide derivatives for inhibiting endoplasmic reticulum (ER) stress
granted -
US 11180452
Methods and compositions for selectively inhibiting pathogenic microbes
granted -
US 10975124
Methods and compositions for treating diseases and conditions associated with gonadotropin releasing hormone receptor
granted -
US 10953113
Imaging agents and methods of use
granted -
US 10953040
Methods of treating bacterial infections with penam β-lactam antibiotics and branched poly(ethylenimine)
granted -
US 10933126
Clostridium difficile immunogenic compositions and methods of use
granted -
US 10899822
Compositions comprising D-amino acid peptides and methods of production and use thereof for inhibiting autoantibodies
granted -
US 10876116
Anti-ARID3a treatments for inflammatory disorders
granted -
US 10815219
2,4-diaminoquinazoline derivatives for inhibiting endoplasmic reticulum (ER) stress
granted -
US 10779517
Animal wound model and methods of use
granted -
US 10723778
Variants of adrenomedullin and calcitonin gene-related peptide and methods of use
granted -
US 10709758
Peptide inhibitors of clostridium difficile toxin B (TcdB) toxin
granted -
US 10640535
Identification of MHC class I phospho-peptide antigens from breast cancer utilizing SHLA technology and complementary enrichment strategies
granted -
US 10584306
Surfactant microemulsions
granted -
US 10562941
Pneumolysin mutants and methods of use thereof
granted -
US 10494619
High isomerohydrolase activity mutants of human RPE65
granted